Ticker Report $WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI) $PACB Barclays Trims Pacific Biosciences of California (NASDAQ:PACB) Target Price to $3.00 $NFLX Netflix, Inc. (NASDAQ:NFLX) Receives $590.15 Consensus Target Price from Brokerages $SNOW Brokerages Set Snowflake Inc. (NYSE:SNOW) Target Price at $202.50 $RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00 $CERE Cerevel Thera...
Analysts believe AbbVie's early acquisition of Cerevel, despite high risks, could potentially yield high returns and avoid bidding wars if emraclidine's data is positive. It's also seen as a strategic move to enhance AbbVie's long-term pipelines.
Analyst Mohit Bansal opines AbbVie might favour purchasing Cerevel due to its perceived clean IP and daily dosing for its principal schizophrenia medication. He anticipates potential benefit from peak adjustments in sales surpassing $3B.
1 | Below is a look at the top insider trades with the biggest value in the past week. Last week, the major shareholder of$Cerevel Therapeutics Holdings(CERE.US)$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at ...
Cerevel Therapeutics Holdings股票討論區
Ticker Report in April
$WIMI Evaluate Research reiterated a "buy" rating with $7 latest price target for WIMI Hologram Cloud(NASDAQ: WIMI)
$PACB Barclays Trims Pacific Biosciences of California (NASDAQ:PACB) Target Price to $3.00
$NFLX Netflix, Inc. (NASDAQ:NFLX) Receives $590.15 Consensus Target Price from Brokerages
$SNOW Brokerages Set Snowflake Inc. (NYSE:SNOW) Target Price at $202.50
$RCI Barclays Trims Rogers Communications (NYSE:RCI) Target Price to $46.00
$CERE Cerevel Thera...
Alerted 22 hit 26
專欄Weekly Insider Money Tracking: Directors of Cerevel Therapeutics Buy Close to $400 Million Worth of Stock
Last week, the major shareholder of $Cerevel Therapeutics Holdings(CERE.US)$, Bain Capital Investors Llc, purchased 5,480,052 shares worth $125 million in a transaction dated October 16th. The other two principal shareholders, Koppel Adam and Gordon Christopher, also bought an equivalent amount of stock at ...
專欄US Top Gap Ups and Downs on 4/24: CS, PHG, BIDU, HTHT and More
Gap Ups
1. $飛利浦(PHG.US)$ - up 13.10%
2. $Wipro(WIT.US)$ - up 2.0%
3. $費森尤斯醫療(FMS.US)$ - up 1.5%
4. $Credit Suisse(CS.US)$ - up 1.1%
5. $埃爾比特系統(ESLT.US)$ - up 1.1%
6. $Cerevel Therapeutics Holdings(CERE.US)$ - up 0.8%
7. $荷蘭全球保險(AEG.US)$ - up 0.7%
8. $道達爾(TTE.US)$ - up 0.4%...
Good news?
暫無評論